What is the Reason That the Pharmacological Future of Chemotherapeutics in the Treatment of Lung Cancer Could Be Most Closely Related to Nanostructures …
K Szupryczyński, P Czeleń, T Jeliński… - International Journal of …, 2024 - Taylor & Francis
Over the course of several decades, anticancer treatment with chemotherapy drugs for lung
cancer has not changed significantly. Unfortunately, this treatment prolongs the patient's life …
cancer has not changed significantly. Unfortunately, this treatment prolongs the patient's life …
Hepatic cell junctions: Pulling a double‐duty
R Van Campenhout, M Vinken - Liver International, 2024 - Wiley Online Library
Cell junctions, including anchoring, occluding and communicating junctions, play an
indispensable role in the structural and functional organization of multicellular tissues …
indispensable role in the structural and functional organization of multicellular tissues …
Comparative effectiveness of glycyrrhizic acid preparations aimed at improving liver function of patients with chronic hepatitis B: a network meta-analysis of 53 …
W Gao, Y Zhao, L Guo, Y Wang, H Gong, B Zhang… - Phytomedicine, 2023 - Elsevier
Background and objectives Entecavir (ETV) has disadvantages, such as poor improvement
in liver function, during the treatment of Chronic hepatitis B (CHB). Thus ETV is often used in …
in liver function, during the treatment of Chronic hepatitis B (CHB). Thus ETV is often used in …
Polyvinylpyrrolidone-Polydatin nanoparticles protect against oxaliplatin induced intestinal toxicity in vitro and in vivo
S Zhou, Y Sun, K Wang, X Gao, K Dong, J Wang… - Food and Chemical …, 2024 - Elsevier
Oxaliplatin (OXL) is a first-line drug for the treatment of colon cancer, with excellent efficacy.
Intestinal toxicity is a common side effect of OXL, with unclear pathogenesis and a lack of …
Intestinal toxicity is a common side effect of OXL, with unclear pathogenesis and a lack of …